Back to Search
Start Over
Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene.
- Source :
-
Biochemical pharmacology [Biochem Pharmacol] 2018 Dec; Vol. 158, pp. 1-12. Date of Electronic Publication: 2018 Sep 22. - Publication Year :
- 2018
-
Abstract
- In its classical genomic mode of action, the aryl hydrocarbon receptor (AhR) acts as a ligand activated transcription factor regulating expression of target genes such as CYP1A1 and CYP1B1. Some ligands may also trigger more rapid nongenomic responses through AhR, including calcium signaling (Ca <superscript>2+</superscript> ). In the present study we observed that pyrene induced a relatively rapid increase in intracellular Ca <superscript>2+</superscript> -concentrations ([Ca <superscript>2+</superscript> ] <subscript>i</subscript> ) in human microvascular endothelial cells (HMEC-1) and human embryonic kidney cells (HEK293) that was attenuated by AhR-inhibitor treatment and/or transient AhR knockdown by RNAi. In silico molecular docking based on homology models, suggested that pyrene is not able to bind to the human AhR in the agonist conformation. Instead, pyrene docked in the antagonist conformation of the AhR PAS-B binding pocket, although the interaction differed from antagonists such as GNF-351 and CH223191. Accordingly, pyrene did not induce CYP1A1 or CYP1B1, but suppressed CYP1-expression by benzo[a]pyrene (B[a]P) in HMEC-1 cells, confirming that pyrene act as an antagonist of AhR-induced gene expression. Use of pharmacological inhibitors and Ca <superscript>2+</superscript> -free medium indicated that the pyrene-induced AhR nongenomic [Ca <superscript>2+</superscript> ] <subscript>i</subscript> increase was initiated by Ca <superscript>2+</superscript> -release from intracellular stores followed by a later phase of extracellular Ca <superscript>2+</superscript> -influx, consistent with store operated calcium entry (SOCE). These effects was accompanied by an AhR-dependent reduction in ordered membrane lipid domains, as determined by di-4-ANEPPDHQ staining. Addition of cholesterol inhibited both the pyrene-induced [Ca <superscript>2+</superscript> ] <subscript>i</subscript> -increase and alterations in membrane lipid order. In conclusion, we propose that pyrene binds to AhR, act as an antagonist of the canonical genomic AhR/Arnt/CYP1-pathway, reduces ordered membrane lipid domains, and activates AhR nongenomic Ca <superscript>2+</superscript> -signaling from intracellular stores.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Subjects :
- Azo Compounds chemistry
Azo Compounds metabolism
Azo Compounds pharmacology
Basic Helix-Loop-Helix Transcription Factors agonists
Basic Helix-Loop-Helix Transcription Factors antagonists & inhibitors
Basic Helix-Loop-Helix Transcription Factors chemistry
Binding Sites
Calcium Signaling drug effects
Endothelial Cells drug effects
Endothelial Cells metabolism
HEK293 Cells
Humans
Indoles chemistry
Indoles metabolism
Indoles pharmacology
Molecular Docking Simulation methods
Protein Structure, Secondary
Purines chemistry
Purines metabolism
Purines pharmacology
Pyrazoles chemistry
Pyrazoles metabolism
Pyrazoles pharmacology
Pyrenes chemistry
Receptors, Aryl Hydrocarbon agonists
Receptors, Aryl Hydrocarbon antagonists & inhibitors
Receptors, Aryl Hydrocarbon chemistry
Basic Helix-Loop-Helix Transcription Factors metabolism
Calcium Signaling physiology
Pyrenes metabolism
Pyrenes pharmacology
Receptors, Aryl Hydrocarbon metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2968
- Volume :
- 158
- Database :
- MEDLINE
- Journal :
- Biochemical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 30248327
- Full Text :
- https://doi.org/10.1016/j.bcp.2018.09.023